Join
Live feed
·
PRReleasevia Quantisnow
Myovant Sciences Ltd. logo
Urovant Sciences Ltd. logo

Urovant Sciences Announces Positive Topline Results of Phase 2a Trial of its Potential Novel Gene Therapy, URO-902

ByQuantisnow·Wall Street's wire, on your screen.
MYOV· Myovant Sciences Ltd.UROV· Urovant Sciences Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MYOV (Myovant Sciences Ltd.), UROV (Urovant Sciences Ltd.) and more on Quantisnow.